Delivra Health Brands Inc. (DHBUF) Research

Delivra Health Brands Inc., leveraging its operational subsidiaries, provides a varied selection of wellness and lifestyle products. These offerings are distributed to consumers and patients within regulated markets globally. The company's diverse product range includes cannabis-based items, liquid and powdered formulations for sleep, and topical creams designed for pain relief. Delivra Health Brands' primary corporate office is located in Vancouver, Canada.

Market snapshot

Symbol
DHBUF
Price
$0.08
Day change
-16.69%
Market cap
$3.1M
P/E ratio
-3.09x
52-week range
0.0502-0.2612
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 4 months

Recent news

  • Delivra Health brands reports e-commerce growth – ICYMI

    Delivra Health Brands Inc. (TSX-V:DHB, OTCQB:DHBUF, FRA:3F0) earlier this week discussed its latest quarterly results, highlighting the impact of...

  • Berkshire Hathaway reports higher Q1 operating earnings under new CEO Greg Abel

    Berkshire Hathaway Inc (NYSE:BRK.A) over the weekend reported higher operating earnings and a record cash position in the first quarter of 2026, marking the...

  • Delivra Health Brands expands LivRelief with Peak Processing Solutions partnership - ICYMI

    Delivra Health Brands Inc. (TSX-V:DHB, OTCQB:DHBUF, FRA:3F0) CEO Gord Davey talked with Proactive about the company's new five-year partnership with Peak Processing Solutions and how it will expand distribution for its LivRelief Infused brand. Proactive: Welcome back inside our Proactive newsroom.

Peer companies

  • Ayr Wellness Inc. (AYRWF)
  • Ayurcann Holdings Corp. (AYURF)
  • Cannabis Bioscience International Holdings, Inc. (CBIH)
  • Christina Lake Cannabis Corp. (CLCFF)
  • Crescita Therapeutics Inc. (CRRTF)
  • CV Sciences, Inc. (CVSI)
  • Healthy Extracts Inc. (HYEX)
  • Ionic Brands Corp. (IONKF)

Open Delivra Health Brands Inc. (DHBUF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.